Area:
Molecular Biology, Neuroscience Biology
We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Kelly D. Karpa is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2014 — 2017 |
Barnett, Joey V. [⬀] Karpa, Kelly D. |
R13Activity Code Description: To support recipient sponsored and directed international, national or regional meetings, conferences and workshops. |
National Pharmacology Directors of Graduate Programs Meeting
DESCRIPTION (provided by applicant): The integration of our scientific knowledge at the molecular, cellular, and organismal levels is critical to impacting disease in humans. As our insight into molecular and cellular processes has grown, emphasis in many Ph.D. training programs has shifted away from integrated (whole animal or systems) biology, including the biology of humans. The lack of an available scientific workforce with an understanding of integrated or human biology, including drug metabolism and pharmacokinetics, and an appreciation of the unique challenges of converting discoveries into therapies will delay the application of discoveries at the molecular and cellular levels to human disease. Scientists trained in the disciplines of Pharmacology and Physiology form an important part of this necessary workforce. This meeting addresses critical issues related to training Pharmacologists and Physiologists and has been planned in response to a perceived and real decline in training programs in these disciplines. The goals of this meeting are to identify common problems and opportunities that face Ph.D. training programs in Pharmacology and Physiology and how best to provide training in these disciplines that are key to translational research. The target audienc for this meeting is Directors of Graduate Training Programs in Pharmacology, Physiology, or other biomedical sciences. This meeting will provide a unique opportunity for these scientists to exchange information and to interact with leaders in industry, government, and academia who help shape these disciplines. A continuing dialogue among Directors of training programs and other scientists with an interest in Ph.D. training is identified as a desired major outcome.
|
0.948 |